Spero Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Spero Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 99% to $96,735,000. The net income raised on $22,806,000 and profit margin reached 24%. Total operating expenses were $75,254,000.
Profit Margin
| 2015 | 0 | -10.15M | |
|---|---|---|---|
| 2016 | 335K | -25.49M | -7609.25% |
| 2017 | 1.97M | -46.09M | -2329.31% |
| 2018 | 3.96M | -41.66M | -1050.48% |
| 2019 | 4.74M | -60.17M | -1268.98% |
| 2020 | 9.33M | -77.51M | -830.86% |
| 2021 | 18.25M | -91.30M | -500.12% |
| 2022 | 48.57M | -48.02M | -98.87% |
| 2023 | 96.73M | 22.80M | 23.58% |
SPRO Income Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
Revenue | 96.73M | 48.57M | 18.25M | 9.33M | 4.74M | 3.96M | 1.97M | 335K | 0 |
Cost of revenue | 367K | 1.54M | 1.11M | 67.00M | 65.77M | 0 | 32.86M | 0 | 11K |
Gross profit | 96.36M | 47.03M | 17.13M | -57.67M | -61.03M | 3.96M | -30.89M | 335K | -11K |
Operating exp. | |||||||||
Research and development | 51.44M | 47.59M | 64.52M | 67.00M | 65.77M | 33.88M | 32.86M | 26.33M | 11.12M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 75.25M | 79.14M | 106.22M | 88.44M | 67.95M | 42.80M | 41.73M | 33.55M | 13.32M |
Operating income | 21.48M | -42.19M | -87.97M | -79.11M | -63.21M | -42.80M | -41.73M | -33.22M | -13.32M |
Other income (expenses), net | 3.92M | -4.21M | -1.78M | 833K | 2.29M | 1.14M | 1.84M | 580K | 174K |
Income before tax | 25.40M | -46.41M | -89.75M | -78.28M | -60.92M | -41.66M | -46.09M | -32.64M | -13.15M |
Income tax expense | 2.59M | 1.61M | 1.54M | -761K | -750K | 1.14M | -363K | -7.73M | -3.17M |
Net income | 22.80M | -48.02M | -91.30M | -77.51M | -60.17M | -41.66M | -46.09M | -25.49M | -10.15M |
Earnings per share | |||||||||
Basic EPS | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
Diluted EPS | 0.43 | -1.28 | -2.96 | -3.46 | -3.31 | -2.6 | -17.82 | -3.86 | -1.54 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |